[RET/PTC Gene Rearrangements in the Sporadic and Radiogenic Thyroid Tumors: Molecular Genetics, Radiobiology and Molecular Epidemiology]
- PMID: 26310016
[RET/PTC Gene Rearrangements in the Sporadic and Radiogenic Thyroid Tumors: Molecular Genetics, Radiobiology and Molecular Epidemiology]
Abstract
A review of molecular genetic, radiobiological and molecular epidemiological studies of gene (chromosome) rearrangements RET/PTC in the cells of the thyroid gland as well as the laws in relation to radiation exposure in vitro, in vivo and human populations identified with them are submitted. The data on the c-RET gene and its chimeric constructs with the gene-donors (RET/PTC rearrangements) are considered. The information about the history of the RET/PTC discovery, their types, carcinogenic potential and specificity both to tumor and non-tumor thyroid disease especially for papillary thyroid carcinoma are provided. The data (seven studies) on the induction of RET/PTC after irradiation of tumor and normal thyroid cells in vitro and mice are reviewed. The mechanisms of RET/PTC induction may be associated with DNA double strand breaks and oxidative stress. Some information (three publications) about the possibility of RET/PTC induction by low doses of radiation with low LET (to 0.1 Gy) is given and it is concluded that their potential evidentiary is generally weak. The achievements in the molecular epidemiology of RET/PTC frequency for exposed and unexposed cohorts are stated. At the same time it is noted that, despite the vast array. of data accumulated from 30 countries of the world and more than 20 years of research, the formed provisions are weakly confirmed statistically and have no base corresponding to the canons of evidence-based medicine. The possibility of use of the RET/PTC presence or their frequencies as markers of the papillary thyroid carcinomas and, specifically, their radiogenic forms, is considered. In the first case the answer may be positive, while in the second, the situation is characterized by uncertainty. Based to the above mentioned we came to a conclusion about the need of a pooled or meta-analysis of the totality of the published data.
Similar articles
-
[Dose-Response Dependences for Frequency of RET/PTC Gene Rearrangements in Papillary Thyroid Carcinoma after Irradiation. Simple Pooling Analysis of Molecular Epidemiological Data].Radiats Biol Radioecol. 2016 Jan-Feb;56(1):5-25. Radiats Biol Radioecol. 2016. PMID: 27245001 Russian.
-
RET/PTC Rearrangements Are Associated with Elevated Postoperative TSH Levels and Multifocal Lesions in Papillary Thyroid Cancer without Concomitant Thyroid Benign Disease.PLoS One. 2016 Nov 1;11(11):e0165596. doi: 10.1371/journal.pone.0165596. eCollection 2016. PLoS One. 2016. PMID: 27802347 Free PMC article.
-
DNA fragile site breakage as a measure of chemical exposure and predictor of individual susceptibility to form oncogenic rearrangements.Carcinogenesis. 2017 Mar 1;38(3):293-301. doi: 10.1093/carcin/bgw210. Carcinogenesis. 2017. PMID: 28069693 Free PMC article.
-
The RET oncogene in papillary thyroid carcinoma.Cancer. 2015 Jul 1;121(13):2137-46. doi: 10.1002/cncr.29044. Epub 2015 Mar 2. Cancer. 2015. PMID: 25731779 Review.
-
A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma.Nat Rev Endocrinol. 2016 Apr;12(4):192-202. doi: 10.1038/nrendo.2016.11. Epub 2016 Feb 12. Nat Rev Endocrinol. 2016. PMID: 26868437 Review.
Cited by
-
Expression of lncRNA-HOTAIR in the serum of patients with lymph node metastasis of papillary thyroid carcinoma and its impact.Oncol Lett. 2020 Jul;20(1):907-913. doi: 10.3892/ol.2020.11620. Epub 2020 May 14. Oncol Lett. 2020. PMID: 32566019 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical